
    
      Study Design

      This is a clinical trial Phase IV, randomized, single-blind, with two arms:

        -  MMR (TV) combined measles, mumps and rubella vaccine produced in Bio-Manguinhos, applied
           to healthy children 12 to 23 months. Multidose presentation, only from one batch.

        -  MMR (GSK-TV), produced by GlaxoSmithKline, the same age. Monodose presentation, only
           from one batch.

      Locations of the study

        -  CMS Heitor Beltrão - Tijuca

        -  CMS Milton Fontess Magarão - Engenho de Dentro

        -  CMS Waldyr Franco - Bangu
    
  